BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
May 6, 2009
View Archived Issues
Report: Global Funding Crisis Endangering Biotech Model
LONDON - The global financial crisis is making the biotech business model unsustainable, says the consultancy Ernst and Young in its 23rd annual report on the industry. (BioWorld International)
Read More
UK's Biotech Problems Bemoaned at Conference
Read More
Resequencing Study May Lead to Better Genetic Counseling
Read More
Vernalis Raises £22M Offering Hefty Discount
Read More
BioXell Shares Plunge on Elocalcitol Miss
Read More
Circ, Elan Partner on Pain Drug Formulation
Read More
Cerep and PerkinElmer Expand Assay Offering
Read More
Pharmaxis Hits the Mark in Phase III Cystic Fibrosis Trial
Read More
Other News To Note
Read More